• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌中 RASSF1A 的表达缺失及其与 K-ras 状态的关系。

Loss of RASSF1A expression in colorectal cancer and its association with K-ras status.

机构信息

Department of Medical Oncology, Cancer Center, The State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, 37 Guo Xue Xiang, Chengdu, Sichuan 610041, China.

出版信息

Biomed Res Int. 2013;2013:976765. doi: 10.1155/2013/976765. Epub 2013 Jun 22.

DOI:10.1155/2013/976765
PMID:23865079
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3705944/
Abstract

BACKGROUND

The RAS-association domain family 1 A (RASSF1A) is a classical member of RAS effectors regulating cell proliferation and apoptosis. Loss of RASSF1A expression may shift the balance towards a growth-promoting effect without the necessity of activating K-ras mutations. Its potential association with K-ras mutations in colorectal cancer (CRC) is unclear.

METHODS

RASSF1A expression was examined in normal mucosa, adenoma, and tumor tissues of colon and rectum, respectively. We examined the association of RASSF1A expression, mutations of K-ras, and EGFR status in 76 primary CRCs. The relationship between clinicopathological characteristics and RASSF1A expression was also analyzed.

RESULTS

RASSF1A expression level decreased progressively in normal mucosa, adenoma and, tumor tissues, and the loss of RASSF1A expression occurred more frequently in tumor tissues. Of 76 primary CRCs, loss of RASSF1A expression and/or K-ras mutations were detected in 77% cases. Loss of RASSF1A expression was more frequent in K-ras wild-type than in mutation cases (63% versus 32%, P = 0.011).

CONCLUSIONS

Our study indicates that loss of RASSF1A may be involved in pathogenesis of CRC, its expression was found predominantly in K-ras wild-type CRCs, suggesting that it may be another way of affecting RAS signaling, in addition to K-ras mutations.

摘要

背景

RAS 相关结构域家族 1A(RASSF1A)是调节细胞增殖和凋亡的 RAS 效应物的经典成员。RASSF1A 表达缺失可能会使细胞生长促进作用的平衡发生倾斜,而无需激活 K-ras 突变。其与结直肠癌(CRC)中 K-ras 突变的潜在关联尚不清楚。

方法

分别检测了结肠和直肠的正常黏膜、腺瘤和肿瘤组织中的 RASSF1A 表达。我们检测了 76 例原发性 CRC 中 RASSF1A 表达、K-ras 突变和 EGFR 状态的相关性。还分析了 RASSF1A 表达与临床病理特征之间的关系。

结果

RASSF1A 表达水平在正常黏膜、腺瘤和肿瘤组织中逐渐降低,且肿瘤组织中 RASSF1A 表达缺失更为频繁。在 76 例原发性 CRC 中,77%的病例存在 RASSF1A 表达缺失和/或 K-ras 突变。RASSF1A 表达缺失在 K-ras 野生型病例中比突变病例更为常见(63%比 32%,P = 0.011)。

结论

我们的研究表明,RASSF1A 的缺失可能参与了 CRC 的发病机制,其表达主要存在于 K-ras 野生型 CRC 中,表明其可能是除 K-ras 突变之外影响 RAS 信号通路的另一种方式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d9b/3705944/a01bc59b3b32/BMRI2013-976765.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d9b/3705944/d97d8599981a/BMRI2013-976765.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d9b/3705944/9b744c9ce4f3/BMRI2013-976765.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d9b/3705944/a01bc59b3b32/BMRI2013-976765.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d9b/3705944/d97d8599981a/BMRI2013-976765.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d9b/3705944/9b744c9ce4f3/BMRI2013-976765.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d9b/3705944/a01bc59b3b32/BMRI2013-976765.003.jpg

相似文献

1
Loss of RASSF1A expression in colorectal cancer and its association with K-ras status.结直肠癌中 RASSF1A 的表达缺失及其与 K-ras 状态的关系。
Biomed Res Int. 2013;2013:976765. doi: 10.1155/2013/976765. Epub 2013 Jun 22.
2
K-ras mutations and RASSF1A promoter methylation in colorectal cancer.结直肠癌中的K-ras突变与RASSF1A启动子甲基化
Oncogene. 2002 May 23;21(23):3792-5. doi: 10.1038/sj.onc.1205466.
3
Is availability of anti-EGFR therapy for the colorectal adenocarcinomas showing fascin expression limited?结蛋白表达的结直肠腺癌是否可用抗 EGFR 治疗?
Target Oncol. 2014 Jun;9(2):171-5. doi: 10.1007/s11523-013-0275-8. Epub 2013 Apr 16.
4
Kras gene mutation and RASSF1A, FHIT and MGMT gene promoter hypermethylation: indicators of tumor staging and metastasis in adenocarcinomatous sporadic colorectal cancer in Indian population.Kras 基因突变和 RASSF1A、FHIT 和 MGMT 基因启动子甲基化:印度人群散发性结直肠腺癌肿瘤分期和转移的指标。
PLoS One. 2013;8(4):e60142. doi: 10.1371/journal.pone.0060142. Epub 2013 Apr 3.
5
Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma.结直肠癌中 KRAS 异构体 KRAS-4A/4B 改变和 KRAS 突变的预后意义。
J Pathol. 2009 Dec;219(4):435-45. doi: 10.1002/path.2625.
6
Oncosuppressor methylation: a possible key role in colon metastatic progression.抑癌基因甲基化:在结直肠转移进展中可能起关键作用。
J Cell Physiol. 2011 Jul;226(7):1934-9. doi: 10.1002/jcp.22524.
7
Epidermal growth factor receptor and K-RAS status in two cohorts of squamous cell carcinomas.表皮生长因子受体和 K-RAS 状态在两个鳞状细胞癌队列中。
BMC Cancer. 2010 May 11;10:189. doi: 10.1186/1471-2407-10-189.
8
Alterations in K-ras, APC and p53-multiple genetic pathway in colorectal cancer among Indians.印度人群中结直肠癌患者K-ras、APC和p53多基因通路的改变
Tumour Biol. 2013 Jun;34(3):1901-11. doi: 10.1007/s13277-013-0734-y. Epub 2013 Mar 24.
9
Analysis of HER-3, insulin growth factor-1, nuclear factor-kB and epidermal growth factor receptor gene copy number in the prediction of clinical outcome for K-RAS wild-type colorectal cancer patients receiving irinotecan-cetuximab.分析 HER-3、胰岛素样生长因子-1、核因子-kB 和表皮生长因子受体基因拷贝数对接受伊立替康-西妥昔单抗治疗的 K-RAS 野生型结直肠癌患者临床结局的预测价值。
Ann Oncol. 2012 Jul;23(7):1706-12. doi: 10.1093/annonc/mdr558. Epub 2011 Nov 23.
10
Frequent involvement of ras-signalling pathways in both polypoid-type and flat-type early-stage colorectal cancers.Ras信号通路频繁参与息肉样型和平坦型早期结直肠癌。
J Exp Clin Cancer Res. 2006 Jun;25(2):235-42.

引用本文的文献

1
Deciphering Promoter Hypermethylation of Genes Encoding for RASSF/Hippo Pathway Reveals the Poor Prognostic Factor of RASSF2 Gene Silencing in Colon Cancers.解读RASSF/河马通路相关基因的启动子高甲基化揭示了RASSF2基因沉默在结肠癌中的不良预后因素。
Cancers (Basel). 2021 Nov 26;13(23):5957. doi: 10.3390/cancers13235957.
2
Methylated circulating tumor DNA as a biomarker for colorectal cancer diagnosis, prognosis, and prediction.甲基化循环肿瘤 DNA 作为结直肠癌诊断、预后和预测的生物标志物。
Clin Epigenetics. 2021 May 17;13(1):111. doi: 10.1186/s13148-021-01095-5.
3
Immunohistochemical Profile of Tumor Suppressor Proteins RASSF1A and LATS1/2 in Relation to p73 and YAP Expression, of Human Inflammatory Bowel Disease and Normal Intestine.

本文引用的文献

1
Antiepidermal growth factor receptor monoclonal antibodies: applications in colorectal cancer.抗表皮生长因子受体单克隆抗体:在结直肠癌中的应用
Chemother Res Pract. 2012;2012:198197. doi: 10.1155/2012/198197. Epub 2012 Oct 8.
2
Aberrant promoter methylation of the RASSF1A and APC genes in epithelial ovarian carcinoma development.RASSF1A 和 APC 基因启动子甲基化异常与卵巢上皮性癌的发生。
Cell Oncol (Dordr). 2012 Dec;35(6):473-9. doi: 10.1007/s13402-012-0106-4. Epub 2012 Oct 10.
3
RAS signalling in the colorectum in health and disease.
肿瘤抑制蛋白RASSF1A和LATS1/2在人类炎症性肠病和正常肠组织中与p73及YAP表达相关的免疫组织化学特征
Pathol Oncol Res. 2020 Jan;26(1):567-574. doi: 10.1007/s12253-018-00575-z. Epub 2019 Jan 2.
4
Hierarchical clustering analysis identifies metastatic colorectal cancers patients with more aggressive phenotype.层次聚类分析可识别出具有更具侵袭性表型的转移性结直肠癌患者。
Oncotarget. 2017 Sep 23;8(50):87782-87794. doi: 10.18632/oncotarget.21213. eCollection 2017 Oct 20.
5
Promoter Methylation of RASSF1A indicates Prognosis for Patients with Stage II and III Colorectal Cancer Treated with Oxaliplatin-Based Chemotherapy.RASSF1A 启动子甲基化预示接受奥沙利铂为基础化疗的 II 期和 III 期结直肠癌患者的预后。
Med Sci Monit. 2017 Nov 12;23:5389-5395. doi: 10.12659/msm.903927.
6
β-catenin interaction with NHERF1 and RASSF1A methylation in metastatic colorectal cancer patients.转移性结直肠癌患者中β-连环蛋白与NHERF1的相互作用及RASSF1A甲基化
Oncotarget. 2016 Oct 18;7(42):67841-67850. doi: 10.18632/oncotarget.12280.
7
Clinical utility of RASSF1A methylation in human malignancies.RASSF1A甲基化在人类恶性肿瘤中的临床应用
Br J Cancer. 2015 Jul 28;113(3):372-81. doi: 10.1038/bjc.2015.221. Epub 2015 Jul 9.
健康与疾病状态下结肠中的RAS信号传导
Cell Commun Adhes. 2012 Feb;19(1):1-9. doi: 10.3109/15419061.2011.649380. Epub 2012 Jan 10.
4
Inverse correlation between EGFR mutation and FHIT, RASSF1A and RUNX3 methylation in lung adenocarcinoma: relation with smoking status.肺腺癌中 EGFR 突变与 FHIT、RASSF1A 和 RUNX3 甲基化呈负相关:与吸烟状况的关系。
Anticancer Res. 2011 Apr;31(4):1211-4.
5
RASSF1A suppresses the activated K-Ras-induced oxidative DNA damage.RASSF1A 抑制激活的 K-Ras 诱导的氧化 DNA 损伤。
Biochem Biophys Res Commun. 2011 Apr 29;408(1):149-53. doi: 10.1016/j.bbrc.2011.03.139. Epub 2011 Apr 5.
6
Methylation associated inactivation of RASSF1A and its synergistic effect with activated K-Ras in nasopharyngeal carcinoma.甲基化相关失活的 RASSF1A 及其与鼻咽癌中激活的 K-Ras 的协同作用。
J Exp Clin Cancer Res. 2009 Dec 30;28(1):160. doi: 10.1186/1756-9966-28-160.
7
CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer.结肠癌中的CpG岛甲基化表型、微卫星不稳定性、BRAF突变与临床结局
Gut. 2009 Jan;58(1):90-6. doi: 10.1136/gut.2008.155473. Epub 2008 Oct 2.
8
RAS signaling in colorectal carcinomas through alteration of RAS, RAF, NF1, and/or RASSF1A.通过RAS、RAF、NF1和/或RASSF1A的改变,在结直肠癌中发生RAS信号传导。
Neoplasia. 2008 Jul;10(7):680-6, 2 p following 686. doi: 10.1593/neo.08312.
9
Hypermethylation of the Ras association domain family 1A (RASSF1A) gene in gallbladder cancer.胆囊癌中Ras关联结构域家族1A(RASSF1A)基因的高甲基化
Mol Cells. 2007 Dec 31;24(3):364-71.
10
RASSF1A polymorphism A133S is associated with early onset breast cancer in BRCA1/2 mutation carriers.RASSF1A基因多态性A133S与BRCA1/2突变携带者的早发性乳腺癌相关。
Cancer Res. 2008 Jan 1;68(1):22-5. doi: 10.1158/0008-5472.CAN-07-5183.